rs4819
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000409735.9(PLD3):c.1326G>A(p.Ala442=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0156 in 1,613,498 control chromosomes in the GnomAD database, including 242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 27 hom., cov: 32)
Exomes 𝑓: 0.016 ( 215 hom. )
Consequence
PLD3
ENST00000409735.9 synonymous
ENST00000409735.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.66
Genes affected
PLD3 (HGNC:17158): (phospholipase D family member 3) This gene encodes a member of the phospholipase D (PLD) family of enzymes that catalyze the hydrolysis of membrane phospholipids. The encoded protein is a single-pass type II membrane protein and contains two PLD phosphodiesterase domains. This protein influences processing of amyloid-beta precursor protein. Mutations in this gene are associated with Alzheimer disease risk. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 19-40378026-G-A is Benign according to our data. Variant chr19-40378026-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 403325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-40378026-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.66 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0132 (2003/152238) while in subpopulation AMR AF= 0.0267 (408/15294). AF 95% confidence interval is 0.0245. There are 27 homozygotes in gnomad4. There are 1004 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2003 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLD3 | NM_012268.4 | c.1326G>A | p.Ala442= | synonymous_variant | 13/13 | ENST00000409735.9 | NP_036400.2 | |
PLD3 | NM_001031696.4 | c.1326G>A | p.Ala442= | synonymous_variant | 13/13 | NP_001026866.1 | ||
PLD3 | NM_001291311.2 | c.1326G>A | p.Ala442= | synonymous_variant | 13/13 | NP_001278240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLD3 | ENST00000409735.9 | c.1326G>A | p.Ala442= | synonymous_variant | 13/13 | 1 | NM_012268.4 | ENSP00000386938 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0131 AC: 2000AN: 152120Hom.: 26 Cov.: 32
GnomAD3 genomes
AF:
AC:
2000
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0133 AC: 3327AN: 250520Hom.: 41 AF XY: 0.0133 AC XY: 1796AN XY: 135414
GnomAD3 exomes
AF:
AC:
3327
AN:
250520
Hom.:
AF XY:
AC XY:
1796
AN XY:
135414
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0159 AC: 23175AN: 1461260Hom.: 215 Cov.: 34 AF XY: 0.0154 AC XY: 11219AN XY: 726924
GnomAD4 exome
AF:
AC:
23175
AN:
1461260
Hom.:
Cov.:
34
AF XY:
AC XY:
11219
AN XY:
726924
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0132 AC: 2003AN: 152238Hom.: 27 Cov.: 32 AF XY: 0.0135 AC XY: 1004AN XY: 74440
GnomAD4 genome
AF:
AC:
2003
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
1004
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
45
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | PLD3: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: frequency. OB 12/23/15: 1.4% in Eur chr, 14 hom in ExAC - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at